Oyen WJ - Search Results

1

Comparison of two region of interest definition methods for metabolic response evaluation with [18F]FDG-PET.

Vriens D, De Geus-Oei LF, Van Laarhoven HW, Van Der Heijden HF, Krabbe PF, Visser EP, Oyen WJ. Vriens D, et al. Among authors: oyen wj. Q J Nucl Med Mol Imaging. 2010 Sep 8. Online ahead of print. Q J Nucl Med Mol Imaging. 2010. PMID: 20827254

2

New concepts in infection/inflammation imaging.

Rennen HJ, Corstens FH, Oyen WJ, Boerman OC. Rennen HJ, et al. Among authors: oyen wj. Q J Nucl Med. 2001 Jun;45(2):167-73. Q J Nucl Med. 2001. PMID: 11476166 Review.

3

Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings.

Drenth JP, Nagengast FM, Oyen WJ. Drenth JP, et al. Among authors: oyen wj. Eur J Nucl Med. 2001 Dec;28(12):1766-9. doi: 10.1007/s002590100645. Epub 2001 Oct 19. Eur J Nucl Med. 2001. PMID: 11734913

4

The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours.

Spermon JR, De Geus-Oei LF, Kiemeney LA, Witjes JA, Oyen WJ. Spermon JR, et al. Among authors: oyen wj. BJU Int. 2002 Apr;89(6):549-56. doi: 10.1046/j.1464-410x.2002.02641.x. BJU Int. 2002. PMID: 11942962

5

Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation.

Bleeker-Rovers CP, de Kleijn EM, Corstens FH, van der Meer JW, Oyen WJ. Bleeker-Rovers CP, et al. Among authors: oyen wj. Eur J Nucl Med Mol Imaging. 2004 Jan;31(1):29-37. doi: 10.1007/s00259-003-1338-3. Epub 2003 Oct 10. Eur J Nucl Med Mol Imaging. 2004. PMID: 14551752

6

FDG-PET in infectious and inflammatory disease.

Oyen WJ, Mansi L. Oyen WJ, et al. Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1568-70. doi: 10.1007/s00259-003-1359-y. Epub 2003 Oct 2. Eur J Nucl Med Mol Imaging. 2003. PMID: 14579098 No abstract available.

7

Radiolabeled chemotactic cytokines: new agents for scintigraphic imaging of infection and inflammation.

van Eerd JE, Boerman OC, Corstens FH, Oyen WJ. van Eerd JE, et al. Among authors: oyen wj. Q J Nucl Med. 2003 Dec;47(4):246-55. Q J Nucl Med. 2003. PMID: 14973417 Free article. Review.

8

Tracers to monitor the response to chemotherapy: in vitro screening of four radiopharmaceuticals.

de Geus-Oei LF, van Eerd-Vismale J, Molthoff C, Corstens F, Oyen W, Boerman O. de Geus-Oei LF, et al. Cancer Biother Radiopharm. 2004 Aug;19(4):457-65. doi: 10.1089/cbr.2004.19.457. Cancer Biother Radiopharm. 2004. PMID: 15453960

9

FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis.

van Kouwen MC, Jansen JB, van Goor H, de Castro S, Oyen WJ, Drenth JP. van Kouwen MC, et al. Among authors: oyen wj. Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):399-404. doi: 10.1007/s00259-004-1689-4. Epub 2004 Nov 12. Eur J Nucl Med Mol Imaging. 2005. PMID: 15549297 Clinical Trial.

10

Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut.

de Groot M, Meeuwis AP, Kok PJ, Corstens FH, Oyen WJ. de Groot M, et al. Among authors: oyen wj. Eur J Nucl Med Mol Imaging. 2005 Jan;32(1):98-101. doi: 10.1007/s00259-004-1670-2. Epub 2004 Oct 5. Eur J Nucl Med Mol Imaging. 2005. PMID: 15605289

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

688 results

Search Page

Filters